Non-thiazolidinedione insulin sensitiser shows promise.
D017326:Clinical Trials, Phase III as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004345:Drug Industry; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D010080:Oxazoles; D013844:Thiazoles; D014443:Tyrosine / Q000031:analogs & derivatives
D007004:Hypoglycemic Agents; D010080:Oxazoles; D013844:Thiazoles; C422415:farglitazar; D014443:Tyrosine